Although extensive studies have demonstrated that CUL3 ubiquitin ligase is involved in diverse cellular processes regulating tumorigenesis and that inhibition of CUL3 sensitizes ovarian cancer cells to cisplatin [36], the precise mechanism by which CUL3 is involved in cellular resistance in cervical cancer has yet to be elucidated. This evidence concerns the gene CUL3 and ovarian carcinoma.